The firm says the decision to relocate is the result of its Berlin property being purchased by a direct competitor.
Tablet manufacturer The Aenova Group (Munich), which serves the medicinal and dietary supplement industries, is moving its tablet-production facility from Berlin to Bavaria, with plans to close the Berlin plant over the next few months.
The company says that equipment and operations will be transferred to sites in Tittmoning and Bad Aibling in Bavaria. It says that overall capacity for manufacturing and packaging tablets will not be affected.
The firm says the decision to relocate is the result of its Berlin property being purchased by a direct competitor.
In June, the company also plans to move production for effervescent tablets from Ticino, Switzerland, to Bad Aibling.
NutriSciences Innovations announces acquisition of XSTO Solutions
October 22nd 2024According to the company’s press release, the strategic acquisition adds six new branded products to the NutriScience portfolio, strengthening its role as a preferred ingredient supplier to leading brands in the wellness, food, and beverage industries.
The Nutritional Outlook Podcast Episode 34: Demystifying Prebiotics and Postbiotics
September 30th 2024In this episode of the Nutritional Outlook Podcast we are looking back on a webcast Nutritional Outlook hosted in May, called “Demystifying the Prebiotic and Postbiotic Markets.” During that event, Sandra Saville, director of education and communication for the International Probiotics Association and Dr. Jessica A. Younes, scientific director of the International Probiotics Association debunked myths about prebiotic and postbiotics, and defined the respective categories to help manufacturers better understand how to responsibly formulate and market prebiotic and postbiotic products.
Balchem’s Newest Launch Optifolin⁺® Brings Innovation to the Folate Market
September 19th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin⁺, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.